Skip to content
zameds

Valgen Co

Active ingredient not listed in the SAHPRA register

Viatris Healthcare (Pty) Ltd

Registration

Applicant
Viatris Healthcare (Pty) Ltd
Registrations
4

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Valgen co 80 mg/12,5 MG80 mg/12,5 mg47125047/7.1.3/1250RegisteredNot determinedNone
Valgen co 160 mg/12,5 MG160 mg/12,5 mg47125147/7.1.3/1251RegisteredNot determinedNone
Valgen co 160 mg/25 MG160 mg/25 mg47125247/7.1.3/1252RegisteredNot determinedNone
Valgen co 320 mg/25 MG320 mg/25 mg47125447/7.1.3/1254RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

No structure available

The SAHPRA register lists no active ingredient for this product, so there is no compound to show.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles